-
1
-
-
0031697688
-
Enhanced fatigue during motor performance in patients with Parkinson's disease
-
Ziv I, Avraham M, Michaelov Y, et al. Enhanced fatigue during motor performance in patients with Parkinson's disease. Neurology 1998;51:1583-1586.
-
(1998)
Neurology
, vol.51
, pp. 1583-1586
-
-
Ziv, I.1
Avraham, M.2
Michaelov, Y.3
-
2
-
-
0026794991
-
The effect of exercise on levodopa absorption
-
Carter JH, Nutt JG, Woodward WR. The effect of exercise on levodopa absorption. Neurology 1992;42:2042-2045.
-
(1992)
Neurology
, vol.42
, pp. 2042-2045
-
-
Carter, J.H.1
Nutt, J.G.2
Woodward, W.R.3
-
3
-
-
0027270391
-
Blood levodopa levels and unified Parkinson's disease rating scale function: With and without exercise
-
Goetz CG, Thelen JA, MacLeod CM, Carvey PM, Bartley EA, Stebbins GT. Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exercise. Neurology 1993;43:1040-1042.
-
(1993)
Neurology
, vol.43
, pp. 1040-1042
-
-
Goetz, C.G.1
Thelen, J.A.2
MacLeod, C.M.3
Carvey, P.M.4
Bartley, E.A.5
Stebbins, G.T.6
-
4
-
-
0023217295
-
Exercise and the antiparkinsonian response to levodopa
-
Mouradian MM, Juncos JL, Serrati C, Fabbrini G, Palmeri S, Chase TN. Exercise and the antiparkinsonian response to levodopa. Clin Neuropharmacol 1987;10:351-355.
-
(1987)
Clin Neuropharmacol
, vol.10
, pp. 351-355
-
-
Mouradian, M.M.1
Juncos, J.L.2
Serrati, C.3
Fabbrini, G.4
Palmeri, S.5
Chase, T.N.6
-
5
-
-
0033809616
-
The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa
-
Reuter I, Harder S, Engelhardt M, Baas H. The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa. Mov Disord 2000;15:862-868.
-
(2000)
Mov Disord
, vol.15
, pp. 862-868
-
-
Reuter, I.1
Harder, S.2
Engelhardt, M.3
Baas, H.4
-
6
-
-
33646946771
-
Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients
-
Müller T, Erdmann C, Bremen D, et al. Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients. Clin Neuropharmacol 2006;29:61-67.
-
(2006)
Clin Neuropharmacol
, vol.29
, pp. 61-67
-
-
Müller, T.1
Erdmann, C.2
Bremen, D.3
-
7
-
-
0342803654
-
Levodopa in plasma correlates with body weight of parkinsonian patients
-
Müller T, Woitalla D, Saft C, Kuhn W. Levodopa in plasma correlates with body weight of parkinsonian patients. Parkinsonism Relat Disord 2000;6:171-173.
-
(2000)
Parkinsonism Relat Disord
, vol.6
, pp. 171-173
-
-
Müller, T.1
Woitalla, D.2
Saft, C.3
Kuhn, W.4
-
8
-
-
0035650616
-
Effects of opioid receptor activation on cardiovascular responses and extracellular monoamines within the rostral ventrolateral medulla during static contraction of skeletal muscle
-
Nauli SM, Maher TJ, Pearce WJ, Ally A. Effects of opioid receptor activation on cardiovascular responses and extracellular monoamines within the rostral ventrolateral medulla during static contraction of skeletal muscle. Neurosci Res 2001;41:373-383.
-
(2001)
Neurosci Res
, vol.41
, pp. 373-383
-
-
Nauli, S.M.1
Maher, T.J.2
Pearce, W.J.3
Ally, A.4
-
9
-
-
0036181480
-
Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions
-
Schad CA, Justice JB, Jr, Holtzman SG. Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions. J Pharmacol Exp Ther 2002;300:932-938.
-
(2002)
J Pharmacol Exp Ther
, vol.300
, pp. 932-938
-
-
Schad, C.A.1
Justice Jr, J.B.2
Holtzman, S.G.3
-
10
-
-
28244474541
-
Human white blood cells synthesize morphine: CYP2D6 modulation
-
Zhu W, Cadet P, Baggerman G, Mantione KJ, Stefano GB. Human white blood cells synthesize morphine: CYP2D6 modulation. J Immunol 2005;175:7357-7362.
-
(2005)
J Immunol
, vol.175
, pp. 7357-7362
-
-
Zhu, W.1
Cadet, P.2
Baggerman, G.3
Mantione, K.J.4
Stefano, G.B.5
|